IVVD Invivyd Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IVVD

Price (delayed)

$2.15

Market cap

$256.33M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.81

Enterprise value

$57.85M

Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has ...

Highlights
Invivyd's debt has decreased by 42% YoY and by 16% QoQ
IVVD's EPS is up by 19% year-on-year but it is down by 17% since the previous quarter
The net income has grown by 18% YoY but it has contracted by 17% from the previous quarter
The quick ratio has plunged by 73% YoY and by 60% from the previous quarter
Invivyd's equity has plunged by 50% YoY and by 28% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://adagiotx.com
Peers: OMER OMGA

Key stats

What are the main financial stats of IVVD
Market
Shares outstanding
119.22M
Market cap
$256.33M
Enterprise value
$57.85M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.33
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$198.64M
EBITDA
-$196.62M
Free cash flow
-$173.78M
Per share
EPS
-$1.81
Free cash flow per share
-$1.59
Book value per share
$1.61
Revenue per share
$0
TBVPS
$2.09
Balance sheet
Total assets
$229.18M
Total liabilities
$51.71M
Debt
$2.17M
Equity
$177.47M
Working capital
$174.59M
Liquidity
Debt to equity
0.01
Current ratio
4.47
Quick ratio
3.99
Net debt/EBITDA
1.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-67.9%
Return on equity
-77%
Return on invested capital
-189.8%
Return on capital employed
-111%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IVVD stock price

How has the Invivyd stock price performed over time
Intraday
3.86%
1 week
-6.52%
1 month
-41.26%
1 year
97.25%
YTD
-45.43%
QTD
-51.58%

Financial performance

How have Invivyd's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$212.76M
Net income
-$198.64M
Gross margin
N/A
Net margin
N/A
Invivyd's operating income has decreased by 28% QoQ but it has increased by 8% YoY
The net income has grown by 18% YoY but it has contracted by 17% from the previous quarter

Growth

What is Invivyd's growth rate over time

Valuation

What is Invivyd stock price valuation
P/E
N/A
P/B
1.33
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
IVVD's EPS is up by 19% year-on-year but it is down by 17% since the previous quarter
Invivyd's equity has plunged by 50% YoY and by 28% from the previous quarter
The price to book (P/B) is 33% higher than the last 4 quarters average of 1.0

Efficiency

How efficient is Invivyd business performance
The ROIC has plunged by 98% from the previous quarter but it has soared by 52% YoY
IVVD's return on equity is down by 38% since the previous quarter and by 28% year-on-year
The company's return on assets fell by 33% QoQ and by 30% YoY

Dividends

What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IVVD.

Financial health

How did Invivyd financials performed over time
IVVD's total liabilities has surged by 90% year-on-year and by 82% since the previous quarter
The quick ratio has plunged by 73% YoY and by 60% from the previous quarter
Invivyd's debt is 99% lower than its equity
Invivyd's equity has plunged by 50% YoY and by 28% from the previous quarter
Invivyd's debt has decreased by 42% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.